EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Saturday 14 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom